Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Lo CJ et al. | Endotoxin-induced macrophage gene expression depends on platelet-activating factor. | 1997 | Arch Surg | pmid:9403541 |
Uozumi N et al. | Role of cytosolic phospholipase A2 in allergic response and parturition. | 1997 | Nature | pmid:9403692 |
Soubeyrand S et al. | Phospholipase A2 from bovine seminal plasma is a platelet-activating factor acetylhydrolase. | 1998 | Biochem. J. | pmid:9405273 |
Coffer PJ et al. | Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. | 1998 | Biochem. J. | pmid:9405284 |
Tabuchi S et al. | Lipid mediators modulate NMDA receptor currents in a Xenopus oocyte expression system. | 1997 | Neurosci. Lett. | pmid:9406868 |
Adachi T et al. | PAF analogues capable of inhibiting PAF acetylhydrolase activity suppress migration of isolated rat cerebellar granule cells. | 1997 | Neurosci. Lett. | pmid:9406887 |
Zinchenko VP et al. | [Effect of structural analogs of platelet activating factor on the intracellular signal transduction in murine peritoneal neutrophils and macrophages of P388D1 line]. | 1997 Sep-Oct | Biofizika | pmid:9410037 |
Camici M et al. | [Platelet activating factor (PAF) and kidney failure progression]. | 1997 | Minerva Med. | pmid:9411309 |
Kertscher HP | [PAF-antagonists with lipid structure. 6. Alkylpropandiol lipids with acyl- and ether- structures at the C-3 position and heterocyclic head groups; synthesis, characterization and structure-activity relationship]. | 1997 | Pharmazie | pmid:9411454 |
Bix GJ and Clark GD | Platelet-activating factor receptor stimulation disrupts neuronal migration In vitro. | 1998 | J. Neurosci. | pmid:9412509 |
Zimmerman GA et al. | Adhesion and signaling in vascular cell-cell interactions. | 1997 | J. Clin. Invest. | pmid:9413392 |
Sozzani S et al. | Human monocyte-derived and CD34+ cell-derived dendritic cells express functional receptors for platelet activating factor. | 1997 | FEBS Lett. | pmid:9414103 |
Manabe H et al. | KF19514, a phosphodieterase 4 and 1 inhibitor, inhibits PAF-induced lung inflammatory responses by inhaled administration in guinea pigs. | 1997 | Int. Arch. Allergy Immunol. | pmid:9414145 |
Maeda T et al. | Hemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor. | 1997 | Acta Neurochir. Suppl. | pmid:9416292 |
Prescott SM | Inflammatory actions of platelet-activating factor: control by PAF acetylhydrolase. | 1997 Sep-Oct | J Investig Allergol Clin Immunol | pmid:9416565 |
Mugnai S et al. | Influence of interleukin 1alpha on superoxide anion, platelet activating factor release and phospholipase A2 activity of naive and sensitized guinea-pig alveolar macrophages. | 1997 | Br. J. Pharmacol. | pmid:9421281 |
Shamsuddin M et al. | Regulation of leukotriene and platelet-activating factor synthesis in human alveolar macrophages. | 1997 | J. Lab. Clin. Med. | pmid:9422335 |
Matheson MJ et al. | Role of platelet activating factor, leukotrienes and polymorphs in the FMLP induced increase in microvascular leakage in rabbit trachea. | 1997 | Respirology | pmid:9424405 |
Hichami A et al. | Modulation of platelet-activating-factor production by incorporation of naturally occurring 1-O-alkylglycerols in phospholipids of human leukemic monocyte-like THP-1 cells. | 1997 | Eur. J. Biochem. | pmid:9428670 |
Igarashi Y | [Physiology of sphingosine 1-phosphate: regulation of cell motility and platelet function]. | 1997 | Seikagaku | pmid:9431007 |
Shindo K et al. | Inhibitory effect of azelastine hydrochloride on synthesis and release of platelet activating factor from human alveolar macrophages. | 1997 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9431823 |
Stack WA and Hawkey CJ | Specific mediator-directed therapy for gastrointestinal diseases. | 1997 | Eur J Gastroenterol Hepatol | pmid:9431894 |
Bennett SA and Birnboim HC | Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor. | 1997 | Mol. Carcinog. | pmid:9433481 |
Dupuis F et al. | Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line. | 1997 | Biochim. Biophys. Acta | pmid:9434130 |
Li CL and Wong YY | The bioavailability of ginkgolides in Ginkgo biloba extracts. | 1997 | Planta Med. | pmid:9434615 |
Albert DH et al. | The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis. | 1998 | J. Pharmacol. Exp. Ther. | pmid:9435164 |
Gamaley IA et al. | Superoxide release is involved in membrane potential changes in mouse peritoneal macrophages. | 1998 | Free Radic. Biol. Med. | pmid:9436627 |
Tsoukatos DC et al. | Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL. | 1997 | Arterioscler. Thromb. Vasc. Biol. | pmid:9437199 |
Curtin ML et al. | Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists. | 1998 | J. Med. Chem. | pmid:9438024 |
De Matos IM et al. | Lung oedema induced by Tityus serrulatus scorpion venom in the rat. | 1997 | Comp. Biochem. Physiol. C, Pharmacol. Toxicol. Endocrinol. | pmid:9440240 |
Kokura S et al. | Effects of rebamipide, a novel anti-ulcer agent, on gastric mucosal injury induced by platelet-activating factor in rats. | 1997 | Dig. Dis. Sci. | pmid:9440637 |
Lee EK and Kehrli ME | Expression of adhesion molecules on neutrophils of periparturient cows and neonatal calves. | 1998 | Am. J. Vet. Res. | pmid:9442240 |
Sugimoto Y et al. | Effects of apafant on PAF-induced downregulation of beta-adrenoceptors in guinea pigs. | 1997 | Methods Find Exp Clin Pharmacol | pmid:9442478 |
Murohara T et al. | Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. | 1998 Jan 6-13 | Circulation | pmid:9443437 |
LeVan TD et al. | Platelet-activating factor induction of activator protein-1 signaling in bronchial epithelial cells. | 1998 | Mol. Pharmacol. | pmid:9443941 |
Nilsson J et al. | Lipoprotein-like phospholipid particles inhibit the smooth muscle cell cytotoxicity of lysophosphatidylcholine and platelet-activating factor. | 1998 | Arterioscler. Thromb. Vasc. Biol. | pmid:9445250 |
Dent G et al. | Protein kinase C inhibition enhances platelet-activating factor-induced eicosanoid production in human eosinophils. | 1998 | Am. J. Respir. Cell Mol. Biol. | pmid:9448055 |
Moore RM et al. | Effect of platelet-activating factor antagonist L-691,880 on low-flow ischemia-reperfusion injury of the large colon in horses. | 1998 Jan-Feb | Vet Surg | pmid:9449176 |
van der Bruggen T et al. | Cytokine-induced protein tyrosine phosphorylation is essential for cytokine priming of human eosinophils. | 1998 | J. Allergy Clin. Immunol. | pmid:9449508 |
Shah BH et al. | Role of phosphatidylinositol 3-kinase in human platelet aggregation. | 1997 | Biochem. Soc. Trans. | pmid:9450028 |
Akagi M et al. | Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats. | 1997 | Arzneimittelforschung | pmid:9450165 |
Hirashima Y et al. | Platelet-activating factor and edema surrounding meningiomas. | 1998 | J. Neurosurg. | pmid:9452240 |
Oancea E et al. | Green fluorescent protein (GFP)-tagged cysteine-rich domains from protein kinase C as fluorescent indicators for diacylglycerol signaling in living cells. | 1998 | J. Cell Biol. | pmid:9456311 |
Suzuki M et al. | Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. | 1998 | Am. J. Physiol. | pmid:9458712 |
Cao Y et al. | Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. | 1998 | J. Biol. Chem. | pmid:9461591 |
Kulikov VI and Muzya GI | Ether lipids and platelet-activating factor: evolution and cellular function. | 1997 | Biochemistry Mosc. | pmid:9461631 |
Sibelius U et al. | Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response. | 1998 | J. Exp. Med. | pmid:9463400 |
Winkler JD et al. | Beta-lactams SB 212047 and SB 216754 are irreversible, time-dependent inhibitors of coenzyme A-independent transacylase. | 1998 | Mol. Pharmacol. | pmid:9463491 |
Kruse-Elliott KT et al. | Role of lipid-derived mediators in tumor necrosis factor-induced endothelin-1 release in vivo. | 1998 | Shock | pmid:9466472 |
Wang HG et al. | The role of endogenous nitric oxide in the sympathetic and hemodynamic response to platelet activating factor-induced hypotension in anesthetized dogs. | 1998 | Shock | pmid:9466475 |
Fadok VA et al. | Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. | 1998 | J. Clin. Invest. | pmid:9466984 |
Singh N et al. | Possible mechanism of alprazolam-induced amnesia in mice. | 1998 | Pharmacology | pmid:9467187 |
Golubeva TS et al. | [Determination of the nucleosomal fragmentation of DNA of ACL cells during their incubation with human platelets]. | 1997 | Biull Eksp Biol Med | pmid:9471253 |
Chupin VV et al. | On the synthesis of platelet-activating factor via acetylation of 1-alkyl-sn-glycero-3-phosphocholine. Formation of structural isomer of PAF in the presence of bases. | 1996 | Chem. Phys. Lipids | pmid:9471401 |
Thakur A et al. | The proinflammatory cytokines and arachidonic acid metabolites in human overnight tears: homeostatic mechanisms. | 1998 | J. Clin. Immunol. | pmid:9475355 |
Miotla JM et al. | Platelet-activating factor plays a pivotal role in the induction of experimental lung injury. | 1998 | Am. J. Respir. Cell Mol. Biol. | pmid:9476906 |
Jung KY et al. | Platelet activating factor antagonist activity of ginsenosides. | 1998 | Biol. Pharm. Bull. | pmid:9477174 |
Renis M et al. | Glutamine synthetase activity and HSP70 levels in cultured rat astrocytes: effect of 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. | 1998 | Brain Res. | pmid:9479063 |
Péterfy M et al. | Cloning and characterization of cDNAs and the gene encoding the mouse platelet-activating factor acetylhydrolase Ib alpha subunit/lissencephaly-1 protein. | 1998 | Genomics | pmid:9479492 |
Antonopoulou S et al. | Identification of a new endogenous platelet-activating factor-like molecule in gingival crevicular fluid. | 1998 | Biochem. J. | pmid:9480892 |
Mason GR et al. | Appropriate background correction for DTPA aerosol clearance. | 1998 | J. Appl. Physiol. | pmid:9480975 |
Erickson KL | Dietary fat, breast cancer, and nonspecific immunity. | 1998 | Nutr. Rev. | pmid:9481130 |
Abu-Zidan FM | Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock. | 1998 | Surgery | pmid:9481416 |
Jocks T et al. | Platelet-activating factor mediates monocyte chemoattractant protein-1 expression in glomerular immune injury. | 1998 | Nephrol. Dial. Transplant. | pmid:9481713 |
Wise H | Activation of the prostaglandin EP4-receptor subtype is highly coupled to inhibition of N-formyl-methionyl-leucyl-phenylalanine-stimulated rat neutrophil aggregation. | 1998 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9482170 |
Ezeamuzie CI and Al-Hage M | Effects of some anti-asthma drugs on human eosinophil superoxide anions release and degranulation. | 1998 | Int. Arch. Allergy Immunol. | pmid:9482706 |
Yamawaki I et al. | Inhaled cromoglycate reduces airway neurogenic inflammation via tachykinin antagonism. | 1997 | Res. Commun. Mol. Pathol. Pharmacol. | pmid:9485521 |
Borman RA et al. | Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro. | 1998 | Br. J. Pharmacol. | pmid:9489610 |
Shi LC et al. | Involvement of platelet-activating factor in cell death induced under ischemia/postischemia-like conditions in an immortalized hippocampal cell line. | 1998 | J. Neurochem. | pmid:9489723 |
Matusiewicz R and Rotkiewicz-Piorun A | Inflammatory cells in skin immunological infiltrations. | 1997 Nov-Dec | J Investig Allergol Clin Immunol | pmid:9491202 |
Yang HO and Han BH | Pinusolidic acid: a platelet-activating factor inhibitor from Biota orientalis. | 1998 | Planta Med. | pmid:9491770 |
Rice SQ et al. | Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor. | 1998 | Biochem. J. | pmid:9494101 |
Moritani C et al. | Activation of platelets in bronchial asthma. | 1998 | Chest | pmid:9498966 |
Pettit EJ and Hallett MB | Ca2+ signalling delays in neutrophils: effects of prior exposure to platelet activating factor or formyl-met-leu-phe. | 1998 | Cell. Signal. | pmid:9502117 |
Kimura K et al. | Modulation of platelet activating factor-induced glycogenolysis in the perfused rat liver after administration of endotoxin in vivo. | 1998 | J. Biochem. | pmid:9504421 |
Roy Baker R and Chang H | Substrate specificities of neuronal nuclear acetyltransferases involved in the synthesis of platelet-activating factor: differences in the use of 1-alkyl and 1-acyl lysophospholipid acceptors. | 1998 | Biochim. Biophys. Acta | pmid:9507140 |
Wilson PG et al. | Acute pancreatitis as a model of sepsis. | 1998 | J. Antimicrob. Chemother. | pmid:9511087 |
Fink MP | Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis. | 1998 | J. Antimicrob. Chemother. | pmid:9511090 |
Qayumi KA et al. | A new platelet-activating factor antagonist (CV-6209) in preservation of heart and lung for transplantation. | 1997 | Cardiovasc Drugs Ther | pmid:9512873 |
Webber SE et al. | PAF-induced secretory hyperresponsiveness in the ferret trachea to bradykinin and its pharmacological inhibition. | 1997 | Pulm Pharmacol Ther | pmid:9514626 |
Balsa D et al. | Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats. | 1997 | Drugs Exp Clin Res | pmid:9515229 |
Chung KF | Platelet activating factor revisited. | 1997 | Thorax | pmid:9516891 |
Shindo K et al. | Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor. | 1997 | Thorax | pmid:9516893 |
Cannon TR et al. | Mechanisms of acute vasodilator response to bacterial lipopolysaccharide in the rat coronary microcirculation. | 1998 | Br. J. Pharmacol. | pmid:9517382 |
Tsuji H et al. | The presence of platelet-activating factor-acetylhydrolase in human middle ear effusions. | 1998 Jan-Feb | ORL J. Otorhinolaryngol. Relat. Spec. | pmid:9519378 |
Lukiw WJ et al. | Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9520467 |
Evangelista S et al. | Antihistaminic and antiallergic properties of dextro-mequitamium iodide in upper and lower guinea pig airways: comparison with azelastine. | 1998 | Gen. Pharmacol. | pmid:9522168 |
Yoshikawa T et al. | alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells. | 1998 | Biofactors | pmid:9523024 |
Lopes-Martins RA et al. | The acute increases in vasomotor tone and blood pressure induced by carotid artery occlusion are modulated by platelet-activating factor (PAF) independently of nitric oxide release. | 1997 | J Lipid Mediat Cell Signal | pmid:9524924 |
Oh-hashi K et al. | Possible mechanisms for the differential effects of high linoleate safflower oil and high alpha-linolenate perilla oil diets on platelet-activating factor production by rat polymorphonuclear leukocytes. | 1997 | J Lipid Mediat Cell Signal | pmid:9524928 |
Diven WF et al. | Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla. | 1998 | Ann. Otol. Rhinol. Laryngol. | pmid:9525240 |
Kulikov VI and Muzya GI | The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions. | 1998 | Biochemistry Mosc. | pmid:9526094 |
Mabilat-Pragnon C et al. | Urokinase localization and activity in isolated eosinophils. | 1997 | Thromb. Res. | pmid:9526961 |
Harris AG et al. | Mechanisms of cell injury in rat mesentery and cremaster muscle. | 1998 | Am. J. Physiol. | pmid:9530215 |
Ostrovsky L et al. | A juxtacrine mechanism for neutrophil adhesion on platelets involves platelet-activating factor and a selectin-dependent activation process. | 1998 | Blood | pmid:9531616 |
Michibayashi T | Different types of vasocontractile responses to noradrenaline in the presence of platelets with platelet activating factor. | 1997 | J Smooth Muscle Res | pmid:9533823 |
Yamada T et al. | Effects of inhaled nitric oxide on platelet-activating factor-induced pulmonary hypertension in dogs. | 1998 | Acta Anaesthesiol Scand | pmid:9542566 |
Ishii I et al. | Agonist-induced sequestration, recycling, and resensitization of platelet-activating factor receptor. Role of cytoplasmic tail phosphorylation in each process. | 1998 | J. Biol. Chem. | pmid:9545329 |
Bonsignore L et al. | One-step synthesis and pharmacological activity of new (N-substituted)amino-spiroalkan-dione derivatives. | 1997 | Farmaco | pmid:9550091 |
Sperber K et al. | Mucin secretion in inflammatory bowel disease: comparison of a macrophage-derived mucin secretagogue (MMS-68) to conventional secretagogues. | 1998 | Inflamm. Bowel Dis. | pmid:9552223 |